Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRG2010 in Parkinson's Disease Patients With Motor Fluctuations
NCT06614153Phase 2Completed
- Sponsor
- Hengrui
- Start
- May 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of HRG2010(II) in Parkinson's disease (PD) (3 arms), sponsored by Hengrui. Primary endpoint: Change from baseline in average percent 'Off' time during waking hours at Day 33. Started May 2023; status: completed.
02
Drugs
HRG2010(II)
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06614153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06614153.